Advanced Wound Care Management Market will become worth US$11,161.6 mn by the end of 2024, Says TMR
/
Date30 Mar 2018
Albany, NY, March 30, 2018 (GLOBE NEWSWIRE) — As per the TMR report, the global advanced wound care management market is likely to display a... Read More →
Notification about disposal of voting rights
/
Date30 Mar 2018
Hereby we inform that notification on voting rights disposal of AB „Gubernija“ has been received. AB „Gubernija“ General Manager Algirdas Čiburys 8-41-591900 Attachments: Respublikos spaustuvė... Read More →
Firm Capital Mortgage Investment Corporation Announces Senior Management Changes and Monthly Cash Dividends
/
Date30 Mar 2018
TORONTO, March 29, 2018 (GLOBE NEWSWIRE) — Firm Capital Mortgage Investment Corporation (the “Corporation”) (TSX:FC) is pleased to announce the following senior management changes, effective... Read More →
Transocean Completes Acquisition of Remaining Songa Offshore Shares
/
Date30 Mar 2018
STEINHAUSEN, Switzerland, March 30, 2018 (GLOBE NEWSWIRE) — Transocean Ltd. (NYSE:RIG) announced today that it completed the previously announced compulsory acquisition of the remaining outstanding... Read More →
Media Advisory: Garland Technology Conducts State of Big Data Survey to Identify Top Priorities for Network Operations and Security Operations Teams
/
Date30 Mar 2018
NEW YORK, March 30, 2018 (GLOBE NEWSWIRE) — Date: March 30, 2018 What: State of Big Data Survey ... Read More →
ESO audited financial results of 2017 has been approved
/
Date30 Mar 2018
Energijos Skirstymo Operatorius AB (hereinafter – ESO, the Company), identification code 304151376, registered office placed at Aguonu str. 24, Vilnius, Republic of Lithuania. The total... Read More →
The Walt Disney Company to Make $1.5 Million Investment to ‘Meet Me at the Park’ Program
/
Date30 Mar 2018
Ashburn, Virginia, March 29, 2018 (GLOBE NEWSWIRE) — The National Recreation and Park Association (NRPA) today announced a $1.5 million contribution from The Walt Disney... Read More →
Unum Therapeutics Announces Pricing of Initial Public Offering
/
Date30 Mar 2018
CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) — Unum Therapeutics Inc. (NASDAQ:UMRX) (“Unum Therapeutics”), a clinical-stage biopharmaceutical company focused on the development of novel immunotherapy... Read More →